Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised atNorth AB
Mandate

Vinge has advised atNorth AB

October 16, 2023 M&A Data protection and processing of personal data Banking and Finance

Vinge has advised atNorth AB, a leading Nordic data center services company that offers responsible, power-efficient, cost-optimized data center hosting facilities and high-performance computing services, in connection with its acquisition of Gompute and its Spanish subsidiary.

Gompute is a leading provider of High Performance Computing (HPC) and data center services. The company is headquartered in Gothenburg.

The acquisition of Gompute will further strengthen atNorth’s position in the fast growing HPC market.

Vinge's team mainly consisted of Peter Sundgren, Ulrich Ziche, Isabelle Wållgren, Elis Allmark, Elsa Strandberg, Tove Hallbäck, Sophia Reutercrona, Clara Klingspor, Nicklas Thorgerzon, Karolina Cohrs, Alexandra Tamm, Anna Ekdahl Roos and Cecilia Loctander.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025